Balchem Corp. (NASDAQ:BCPC) Director Dino A. Rossi sold 16,400 shares of the company’s stock in a transaction on Friday, October 7th. The stock was sold at an average price of $78.57, for a total transaction of $1,288,548.00. Following the transaction, the director now owns 23,248 shares of the company’s stock, valued at approximately $1,826,595.36. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Balchem Corp. (NASDAQ:BCPC) opened at 78.22 on Friday. The stock has a market cap of $2.47 billion, a P/E ratio of 44.44 and a beta of 0.61. Balchem Corp. has a 12 month low of $53.11 and a 12 month high of $79.49. The firm’s 50-day moving average is $70.77 and its 200-day moving average is $64.16.

Balchem Corp. (NASDAQ:BCPC) last issued its quarterly earnings results on Friday, August 5th. The company reported $0.44 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.65 by $0.21. The company earned $138.80 million during the quarter, compared to the consensus estimate of $134.77 million. Balchem Corp. had a return on equity of 16.85% and a net margin of 10.18%. On average, equities analysts forecast that Balchem Corp. will post $2.57 earnings per share for the current fiscal year.

Insider Buying and Selling by Quarter for Balchem Corp. (NASDAQ:BCPC)

Separately, Pivotal Research restated a “hold” rating and set a $65.00 price objective on shares of Balchem Corp. in a research report on Sunday, August 7th.

About Balchem Corp.

Balchem Corporation (Balchem) is engaged in the development, manufacture, distribution and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical and medical sterilization industries. The Company operates in four segments: SensoryEffects, Animal Nutrition & Health (ANH), Specialty Products and Industrial Products.

5 Day Chart for NASDAQ:BCPC

Receive News & Stock Ratings for Balchem Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem Corp. and related stocks with our FREE daily email newsletter.